<?xml version="1.0" encoding="UTF-8" ?><rss 
        version         = "2.0"
        xmlns:content   = "http://purl.org/rss/1.0/modules/content/"
        xmlns:wfw       = "http://wellformedweb.org/CommentAPI/"
        xmlns:dc        = "http://purl.org/dc/elements/1.1/"
        xmlns:atom      = "http://www.w3.org/2005/Atom"
        xmlns:sy        = "http://purl.org/rss/1.0/modules/syndication/"
        xmlns:slash     = "http://purl.org/rss/1.0/modules/slash/"
        type            = "0"
                >
        <channel><item post_id='86755'><title>GemPharmatech und Charles River Laboratories unterzeichnen exklusive Vereinbarung über den Vertrieb des NCG-Portfolios der nächsten Generation</title><link>https://business24.ch/2022/07/27/gempharmatech-und-charles-river-laboratories-unterzeichnen-exklusive-vereinbarung-ueber-den-vertrieb-des-ncg-portfolios-der-naechsten-generation/</link><pubDate>Wed, 27 Jul 2022 11:00:01 +0000</pubDate>		<category><![CDATA[Presseportal]]></category>
		<category><![CDATA[noinjection]]></category>
<guid isPermalink='false'>https://business24.ch/?p=86755</guid><post-id xmlns="com-wordpress:feed-additions:1">86755</post-id></item></channel>
      </rss>